40 /100
MEDIUM RISK
Score updated Jun 14, 2026

CBL — CBL & Associates Properties, Inc. Dilution Risk Tracker

Track CBL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CBL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CBL.
🔔 Track CBL — Get forecast alerts →

💹 Market Data

Market Cap$1.49B
Shares Outstanding30.94M
Float17.03M
Cash$122.74M
Debt$4.18B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 23.8% shares (2026Q1 vs prior)
195 institutional holders · 30.51M shares
#1 CANYON CAPITAL ADVISORS LLC 8.47M shares
#2 OAKTREE CAPITAL MANAGEMENT LP 6.46M shares
#3 BlackRock, Inc. 1.79M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest837.6K
Days to Cover3.7
% of Float4.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2014
4 INSIDER TRANSACTION Apr 09, 2026
4 INSIDER TRANSACTION Apr 08, 2026
8-K 8K EVENT Apr 02, 2026
8-K 8K EVENT Mar 19, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CBL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CBL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for CBL
📊 CBL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CBL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.